Henry Schein Inc. (NASDAQ: HSIC) announced plans to reduce its board of directors from 15 to 10 members following its 2026 annual meeting of stockholders scheduled for May 21, 2026.

Stanley M. Bergman will retire from the board after serving 44 years as a director. The board will designate Bergman as chairman emeritus effective immediately following the 2026 annual meeting. Four other directors—Joseph L. Herring, Robert J. Hombach, Scott Serota, and Bradley T. Sheares—will not stand for reelection.

"As I transition to the role of Chairman Emeritus, I do so with deep confidence in our leadership and the future of this organization," Bergman said in a statement. "Fred Lowery is the right person to lead Henry Schein into the next chapter, bringing vision, strong values, and a commitment to excellence."

The 10 incumbent directors nominated for election at the 2026 annual meeting are Mohamad Ali, William K. Daniel, Deborah Derby, Carole T. Faig, Kurt P. Kuehn, Philip A. Laskawy, Max Lin, Frederick M. Lowery, Anne H. Margulies, and Reed V. Tuckson.

Philip Laskawy, lead director of Henry Schein's board, expressed gratitude for the retiring directors' contributions and stated the new slate would "continue to enable robust dialogue and debate in the boardroom while maintaining the right mix of perspectives, experience and skills."

Henry Schein, headquartered in Melville, New York, is a healthcare solutions provider serving dental and medical practitioners. The company reported sales of $13.2 billion in 2025 and operates in 34 countries and territories with approximately 25,000 employees.